These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15950561)

  • 1. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events.
    Marzocchi A; Piovaccari G; Manari A; Aurier E; Benassi A; Saia F; Casella G; Varani E; Santarelli A; Guastaroba P; Grilli R; Maresta A
    Am J Cardiol; 2005 Jun; 95(12):1409-14. PubMed ID: 15950561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy).
    Ortolani P; Ardissino D; Cavallini C; Bramucci E; Indolfi C; Aquilina M; Marzocchi A
    Am J Cardiol; 2005 Nov; 96(10):1393-8. PubMed ID: 16275185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty.
    Cheneau E; Rha SW; Kuchulakanti PK; Stabile E; Kinnaird T; Torguson R; Pichard AD; Satler LF; Kent KM; Waksman R
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):469-72. PubMed ID: 15988741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombus-laden lesions.
    Weber F; Schneider H; Schwarz C; Holzhausen C; Petzsch M; Nienaber CA
    Z Kardiol; 2004 Dec; 93(12):938-43. PubMed ID: 15599568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients.
    Yachi S; Tanabe K; Tanimoto S; Aoki J; Nakazawa G; Yamamoto H; Otsuki S; Yagishita A; Kishi S; Nakano M; Taniwaki M; Sasaki S; Nakajima H; Mise N; Sugimoto T; Hara K
    Am J Kidney Dis; 2009 Aug; 54(2):299-306. PubMed ID: 19394736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
    Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB;
    Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies.
    Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Fernandez C; Escaned J; Bañuelos C; Bethencourt A; López-Mínguez JR; Angel J; Cequier A; Sabaté M; Morís C; Zueco J; Seabra-Gomes R;
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):459-67. PubMed ID: 18814274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents.
    Burzotta F; Siviglia M; Altamura L; Trani C; Leone AM; Romagnoli E; Mazzari MA; Mongiardo R; Niccoli G; Brancati M; Biondi-Zoccai G; Rebuzzi AG; Schiavoni G; Crea F
    Am J Cardiol; 2007 Feb; 99(3):364-8. PubMed ID: 17261399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective native coronary artery stenosis treated with sirolimus-eluting stent (ONASSIS) registry--acute results and mid-term outcomes: a single-center experience.
    Voudris V; Alexopoulos E; Karyofillis P; Malakos J; Manginas A; Spargias C; Pavlides G; Patsilinakos S; Anyfantakis A; Cokkinos DV
    J Invasive Cardiol; 2005 Aug; 17(8):401-5. PubMed ID: 16079443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis.
    Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP
    Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
    Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
    Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
    Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Daemen J; Ong AT; Stefanini GG; Tsuchida K; Spindler H; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
    Am J Cardiol; 2006 Oct; 98(7):895-901. PubMed ID: 16996869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).
    Spaulding C; Teiger E; Commeau P; Varenne O; Bramucci E; Slama M; Beatt K; Tirouvanziam A; Polonski L; Stella PR; Clugston R; Fajadet J; de Boisgelin X; Bode C; Carrié D; Erglis A; Merkely B; Hosten S; Cebrian A; Wang P; Stoll HP; Henry P
    JACC Cardiovasc Interv; 2011 Jan; 4(1):14-23. PubMed ID: 21251624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
    Chacko R; Mulhearn M; Novack V; Novack L; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
    JACC Cardiovasc Interv; 2009 Jun; 2(6):498-503. PubMed ID: 19539252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
    Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
    Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of sirolimus-eluting stents versus bare metal stents for diabetic patients undergoing elective percutaneous coronary intervention.
    Aoki J; Ong A; Rodriguez-Granillo G; VanMieghem C; Daemen J; Sonnenschein K; McFadden E; Sianos G; van der Giessen W; de Feyter P; van Domburg R; Serruys P
    J Invasive Cardiol; 2005 Jul; 17(7):344-8. PubMed ID: 16003016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.